Subtype
Malignant Neck Neoplasm
CI-CAN-00001148Explore in graph →
607 active trials11 approved drugs67 evidence items
- NCIt
- C4940
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001148Explore in graph →
Clinical trials
2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03639662 | Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer | unknown | N/A | 232 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT03636945 | Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma(TEPCMT) | unknown | N/A | 62 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 17, 2018 |
| clinicaltrials |
| NCT03612219 | Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 240 | Wei JiangOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03578575 | To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal Carcinoma | unknown | Phase 2 | 120 | China Medical University HospitalOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | unknown | Phase 3 | 204 | Guiyang Medical UniversityOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03604588 | Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers(HPV OncoTect™) | unknown | N/A | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 27, 2018 | clinicaltrials |
| NCT02602717 | The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study.(Tgcyto) | unknown | N/A | 110 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03595410 | Nomograms to Precisely Predict Conditional Risk of Recurrence for Patients With Laryngeal Cancer | unknown | — | 300 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03588403 | TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients | unknown | — | 110 | Zhejiang Cancer HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | unknown | Phase 3 | 266 | Guiyang Medical UniversityOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03568032 | Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma | unknown | — | 248 | Fudan UniversityOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT02839655 | Prospective Study Assessing Thyroidectomy Using Robot(EVATAR) | unknown | Phase 2 | 17 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 15, 2018 | clinicaltrials |
| NCT03529279 | CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy | unknown | Phase 3 | 1,324 | Sun Yat-sen UniversityOTHER | 0 | May 18, 2018 | clinicaltrials |
| NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 440 | Wei JiangOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03130270 | Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 29 | Guilin Medical University, ChinaOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC(NX-NPC) | unknown | Phase 3 | 632 | Sun Yat-sen UniversityOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT03514251 | Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery | unknown | N/A | 400 | Bo Wang,MDOTHER | 1 | May 2, 2018 | clinicaltrials |
| NCT03510143 | Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery | unknown | N/A | 330 | Seoul National University HospitalOTHER | 1 | Apr 27, 2018 | clinicaltrials |
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | unknown | Phase 1 | 49 | National Cancer Centre, SingaporeOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01872962 | Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 480 | Sun Yat-sen UniversityOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT03500666 | Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection | unknown | N/A | 10 | Fujian Medical UniversityOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03469544 | Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer | unknown | — | 90 | Assiut UniversityOTHER | 0 | Mar 19, 2018 | clinicaltrials |
| NCT03202173 | The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy | unknown | N/A | 31 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT03411954 | Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients | unknown | — | 100 | Zhejiang Cancer HospitalOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT03387943 | PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma | unknown | Phase 2 | 30 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Jan 3, 2018 | clinicaltrials |
| NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | unknown | Phase 2 | 328 | Yun-fei XiaOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03344068 | Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 408 | Sun Yat-sen UniversityOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03045484 | Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy | unknown | N/A | 70 | Sun Yat-sen UniversityOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT03290001 | The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients | unknown | — | 1,000 | Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 2 | 184 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT03300765 | Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer | unknown | Phase 2 | 20 | Xiayun He, MDOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT03282617 | Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 1 | 55 | National University Hospital, SingaporeOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT03268785 | Intra-operative Rapid Identification of Lymph Node and Parathyroid | unknown | N/A | 200 | Xijing HospitalOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT03213587 | Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | unknown | Phase 2 | 51 | Zhejiang Cancer HospitalOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT03210389 | A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2017 | clinicaltrials |
| NCT03003182 | A Study of Nasopharyngeal Carcinoma From Guangdong | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jun 15, 2017 | clinicaltrials |
| NCT03158324 | Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 | unknown | Phase 2 | 52 | National University Hospital, SingaporeOTHER | 1 | Jun 15, 2017 | clinicaltrials |
| NCT03170804 | Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer | unknown | — | 200 | Aventura Hospital and Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03167385 | Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC(De-ESCALaTE) | unknown | Phase 3 | 334 | University of WarwickOTHER | 3 | May 8, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT03087695 | Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma | unknown | — | 200 | Taichung Veterans General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT03068936 | IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma | unknown | Phase 3 | 716 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Mar 3, 2017 | clinicaltrials |
| NCT03058432 | Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 122 | Zhejiang Cancer HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT03039465 | A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients(TEP) | unknown | N/A | 50 | HealthCare Global Enterprise Ltd.INDUSTRY | 1 | Feb 1, 2017 | clinicaltrials |
| NCT02878889 | A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. | unknown | Phase 2 | 53 | Zhejiang Cancer HospitalOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT03015727 | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma(IRCNPC) | unknown | Phase 3 | 440 | Zhejiang Cancer HospitalOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT03006588 | EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients | unknown | Phase 2 / Phase 3 | 100 | Sun Yat-sen UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT03006289 | Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer | unknown | — | 3,000 | Lin LiaoOTHER | 0 | Dec 30, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Aug 21, 2018source: clinicaltrials